- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07842328
Feasibility of a Robot-Guided Active Play Intervention for Children With Cerebral Palsy (REACT)
Robotic Engagement for Active Children's Therapy (REACT): NAO Cerebral Palsy Intervention
Cerebral palsy can make it difficult for children and adolescents to participate consistently in enjoyable physical activity. This study will examine whether a small humanoid robot called NAO can deliver a short, story-based active-play session that encourages movement and participation. Children and adolescents with cerebral palsy will complete one session at BC Children's Hospital. The study will assess whether the intervention is practical to deliver, acceptable to children and caregivers, and safe to use. Participants and caregivers will also provide feedback about their experience. The findings will be used to refine the intervention and plan a future larger trial.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
This is a single-session, single-arm, mixed-methods feasibility and acceptability study of a humanoid social robot-delivered, movement-based narrative active-play intervention for children and adolescents with cerebral palsy. The intervention is delivered by the NAO humanoid robot and is structured as a guided story in which the participant and robot move together through a sequence of physical actions. The intervention is designed around engagement and active participation rather than conventional prescriptive exercise delivery.
Participants across Gross Motor Function Classification System (GMFCS) Levels I-IV will complete an in-person session at BC Children's Hospital. The protocol includes parallel ambulatory and non-ambulatory versions that share a common narrative structure and movement library. During the session, behavioural, physiological, and movement-related information will be collected to characterize participant engagement and physical activity. Following the intervention, children or adolescents and their caregivers will complete measures related to engagement, exertion, comfort, acceptability, willingness to participate in the future, and their experience of the intervention. Semi-structured exit interviews will also be conducted.
The primary purpose of the study is to determine the feasibility and acceptability of delivering the intervention. Feasibility will be characterized using indicators including recruitment and consent, session completion, intervention fidelity, protocol deviations, adverse events, and measurement-protocol completeness. Qualitative feedback will be used to identify barriers, facilitators, and potential modifications to the intervention and study procedures.
The study is not designed or powered to evaluate intervention efficacy. Findings will instead be used to refine the intervention, study procedures, and outcome measures and to inform the design of a future definitive randomized controlled trial.
Tipo di studio
Iscrizione (Stimato)
Fase
- Non applicabile
Contatti e Sedi
Contatto studio
- Nome: Jordan Stevenson, MSc
- Numero di telefono: 604-875-3923
- Email: jordan.stevenson@ubc.ca
Backup dei contatti dello studio
- Nome: Julie Robillard, PhD
- Numero di telefono: 604-875-3923
- Email: julie.robillard@ubc.ca
Luoghi di studio
-
-
British Columbia
-
Vancouver, British Columbia, Canada, V6H 3N1
- BC Children's Hospital
-
Contatto:
- Jordan Stevenson, MSc
- Numero di telefono: 604-875-3923
- Email: jordan.stevenson@ubc.ca
-
Contatto:
- Julie Robillard, PhD
- Numero di telefono: 604-875-3923
- Email: julie.robillard@ubc.ca
-
Investigatore principale:
- Julie Robillard, PhD
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
Children & adolescents -
- Aged 6-18 years with cerebral palsy
- Gross Motor Function Classification System (GMFCS) Level I-IV
- Sufficient receptive English language ability to follow simple verbal instructions from NAO and respond to interview questions, with or without caregiver or communication-aid support
Parent/caregiver -
- Aged 19 years or older
- Sufficient receptive English language ability to participate in interview and survey questions
Additional participation requirements -
- Able to attend an in-person study visit at BC Children's Hospital
- Enrollment is at the dyad level: each child/adolescent must participate with a parent/caregiver, and neither may participate independently
Exclusion Criteria:
- GMFCS Level V
- Uncontrolled seizure disorder or seizure within the previous 6 months
- Severe visual or auditory impairment uncorrected by aids that would prevent interaction with NAO
- Significant cognitive or communication impairment precluding assent and interview participation
- Acute illness or cardiovascular condition contraindicating light-to-moderate physical activity
Additional consideration:
- Individuals will be encouraged not to participate if the child or caregiver reports a fear of robots
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Altro
- Assegnazione: N / A
- Modello interventistico: Assegnazione di gruppo singolo
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: NAO-Guided Active Play Intervention
Participants will complete one in-person, NAO-delivered, movement-based narrative active-play session. The intervention includes parallel ambulatory (GMFCS I-III) and non-ambulatory (GMFCS IV) versions, with both versions sharing a common narrative structure and movement library. |
A humanoid social robot (NAO, SoftBank Robotics) guides the participant through a single, story-based active-play session in which physical movements are embedded within a narrative. The intervention is designed to promote engagement and active participation rather than conventional prescriptive exercise delivery. Parallel ambulatory (GMFCS I-III) and non-ambulatory (GMFCS IV) versions are used, with both sharing a common narrative structure and movement library.
Altri nomi:
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Recruitment Rate
Lasso di tempo: From recruitment initiation through completion of enrollment, anticipated up to 15 months
|
Number of child/adolescent participants enrolled relative to the prespecified recruitment target. Recruitment will be summarized descriptively. Progression will be interpreted as: target achieved = proceed; below target but recruitment achievable with an adjusted strategy or timeline = proceed with modification; below target with no feasible recruitment pathway = reconsider. |
From recruitment initiation through completion of enrollment, anticipated up to 15 months
|
|
Consent Rate
Lasso di tempo: From recruitment initiation through completion of enrollment, anticipated up to 15 months
|
Percentage of eligible child-caregiver dyads invited to participate who provide caregiver consent and child/adolescent assent and enroll in the study. Prespecified progression thresholds are ≥80% = proceed; 60-79% = proceed with modification; <60% = reconsider. |
From recruitment initiation through completion of enrollment, anticipated up to 15 months
|
|
Session Completion Rate
Lasso di tempo: At completion of the approximately 12-minute intervention during the single study visit
|
Percentage of enrolled child/adolescent participants who complete the planned NAO-guided active-play intervention session. Prespecified progression thresholds are ≥80% = proceed; 60-79% = proceed with modification; <60% = reconsider. |
At completion of the approximately 12-minute intervention during the single study visit
|
|
Intervention Fidelity
Lasso di tempo: At completion of the approximately 12-minute intervention during the single study visit
|
Fidelity to the prespecified NAO-guided intervention protocol will be assessed using the approved intervention fidelity checklist and summarized as a percentage. Prespecified progression thresholds are ≥80% = proceed; 60-79% = proceed with modification; <60% = reconsider. |
At completion of the approximately 12-minute intervention during the single study visit
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Protocol Deviations
Lasso di tempo: At completion of the approximately 90-minute study visit (Day 1), based on deviations recorded throughout the visit
|
Number and nature of protocol deviations occurring during study participation, recorded using the approved protocol deviation and adverse event log and summarized descriptively. |
At completion of the approximately 90-minute study visit (Day 1), based on deviations recorded throughout the visit
|
|
Adverse Events
Lasso di tempo: From enrollment through completion of the single study visit, approximately 90 minutes
|
Number and nature of adverse events occurring during study participation, recorded using the approved protocol deviation and adverse event log and summarized descriptively. |
From enrollment through completion of the single study visit, approximately 90 minutes
|
|
REACT Post-Narrative Intervention Likert Scale: Child/Adolescent Engagement and Intention to Repeat
Lasso di tempo: Immediately following the intervention during the single study visit
|
Child/adolescent engagement and intention to repeat the activity will be assessed using the age-appropriate REACT Post-Narrative Intervention Likert Scale (child version, ages 6-13; adolescent version, ages 14-18). Each version contains five items assessing enjoyment, desire to continue the activity, ease of performing the movements, experience interacting with NAO, and willingness to participate in a similar session again. Each item is rated from 1 to 5, with higher scores indicating a more positive response on that item. Responses will be summarized descriptively at the item level; no composite or total score will be calculated. |
Immediately following the intervention during the single study visit
|
|
REACT Caregiver Acceptability and Willingness Survey
Lasso di tempo: Immediately following the intervention during the single study visit
|
Caregiver acceptability and willingness will be assessed using the purpose-built REACT Caregiver Acceptability and Willingness Survey. The survey contains 10 Likert items assessing perceived child enjoyment, engagement, comfort and safety, overall experience, willingness to participate again, willingness to participate in a longer program, comfort with use in therapy or at home, and willingness to recommend the session to other families. Each item is rated from 1 (strongly disagree) to 5 (strongly agree), with higher scores indicating greater agreement and a more positive response on that item. Responses will be summarized descriptively at the item level; no composite or total score will be calculated. |
Immediately following the intervention during the single study visit
|
|
Participant-Reported Session Length and Sensor Comfort via REACT Facilitator Interview Guide
Lasso di tempo: During the approximately 30-minute post-intervention interview conducted during the single study visit
|
Child/adolescent perceptions of intervention length and comfort while wearing the arm-strap heart-rate monitor and wrist-worn accelerometer will be assessed using purpose-built questions and prompts in the REACT Facilitator Interview Guide. Participants will be asked whether the activity felt too long, too short, or appropriate in length and whether the study sensors caused discomfort or were noticeable during participation. Responses will be analyzed qualitatively; no numerical scale or composite score will be calculated. |
During the approximately 30-minute post-intervention interview conducted during the single study visit
|
|
Participant and Caregiver Qualitative Experience
Lasso di tempo: Immediately following the intervention; approximately 30-minute interview during the single study visit
|
A semi-structured dyadic interview with the child/adolescent and caregiver will explore their experience of the NAO-guided active-play intervention, including perceived acceptability, what worked or did not work, barriers and facilitators to participation, and recommended refinements to the intervention and study procedures. |
Immediately following the intervention; approximately 30-minute interview during the single study visit
|
Altre misure di risultato
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
OMNI Rating of Perceived Exertion Scale: Perceived Exertion
Lasso di tempo: Immediately following the approximately 12-minute intervention
|
Child/adolescent perceived exertion will be assessed using the cerebral palsy-specific OMNI Rating of Perceived Exertion scale, with ambulatory and non-ambulatory pictorial versions used as appropriate. The scale ranges from 0 ("not tired at all") to 10 ("very, very tired"), with higher scores indicating greater perceived exertion. Higher scores do not inherently represent a better or worse outcome. |
Immediately following the approximately 12-minute intervention
|
|
Heart Rate Response
Lasso di tempo: During a 2-minute resting baseline and the approximately 12-minute intervention
|
Heart rate will be recorded using an arm-strap heart rate monitor during a seated resting baseline and the NAO-guided active-play intervention. Heart rate data will be summarized descriptively to characterize physiological response during participation. |
During a 2-minute resting baseline and the approximately 12-minute intervention
|
|
Accelerometer-Derived Movement Output
Lasso di tempo: During the 2-minute seated resting baseline and the approximately 12-minute NAO-guided intervention during the single study visit
|
Movement data will be collected using a wrist-worn accelerometer and summarized descriptively to characterize movement and physical activity during the NAO-guided active-play intervention. |
During the 2-minute seated resting baseline and the approximately 12-minute NAO-guided intervention during the single study visit
|
|
Sensor Wear Time
Lasso di tempo: From sensor placement before the 2-minute resting baseline through sensor removal immediately following the approximately 12-minute NAO-guided intervention during the single study visit.
|
Wear time for the arm-strap heart-rate monitor and wrist-worn accelerometer will be recorded in minutes from initial sensor placement to removal. Wear time will be summarized descriptively for each sensor separately; no combined wear-time score will be calculated. |
From sensor placement before the 2-minute resting baseline through sensor removal immediately following the approximately 12-minute NAO-guided intervention during the single study visit.
|
|
Sensor Device-Removal Events
Lasso di tempo: From sensor placement before the 2-minute resting baseline through completion of the approximately 12-minute NAO-guided intervention during the single study visit
|
The number of heart-rate monitor and accelerometer removal events occurring during the planned sensor-wear period will be recorded and summarized descriptively as counts. Events will be reported by sensor type. |
From sensor placement before the 2-minute resting baseline through completion of the approximately 12-minute NAO-guided intervention during the single study visit
|
|
Per-Instrument Sensor Data Completeness
Lasso di tempo: From the 2-minute resting baseline through completion of the approximately 12-minute NAO-guided intervention during the single study visit
|
Data completeness will be assessed separately for the arm-strap heart-rate monitor and wrist-worn accelerometer as the percentage of the planned recording period for which sensor data are available. Higher percentages indicate greater data completeness. Heart-rate and accelerometer completeness will be reported separately; no combined score will be calculated. |
From the 2-minute resting baseline through completion of the approximately 12-minute NAO-guided intervention during the single study visit
|
|
Behavioural Engagement Assessed Using a Study-Specific Structured Video Coding Protocol
Lasso di tempo: During the approximately 12-minute NAO-guided intervention during the single study visit (Day 1)
|
Behavioural engagement during the NAO-guided intervention will be assessed from video recordings using a study-specific structured coding protocol developed and piloted by two independent coders. Behavioural engagement codes will be summarized descriptively; no standardized scale or composite score will be calculated. Inter-rater reliability will be established on a minimum of 20% of recordings, with a target Cohen's κ ≥0.70 before full coding. |
During the approximately 12-minute NAO-guided intervention during the single study visit (Day 1)
|
|
Movement Quality Assessed Using a Study-Specific Structured Video Coding Protocol
Lasso di tempo: During the approximately 12-minute NAO-guided intervention during the single study visit (Day 1)
|
Movement quality during the NAO-guided intervention will be assessed from video recordings using a study-specific structured coding protocol developed and piloted by two independent coders. Movement-quality codes will be summarized descriptively; no standardized scale or composite score will be calculated. Inter-rater reliability will be established on a minimum of 20% of recordings, with a target Cohen's κ ≥0.70 before full coding. |
During the approximately 12-minute NAO-guided intervention during the single study visit (Day 1)
|
|
Critical Incidents Assessed Using a Study-Specific Structured Video Coding Protocol
Lasso di tempo: During the approximately 12-minute NAO-guided intervention during the single study visit (Day 1)
|
Critical incidents occurring during the NAO-guided intervention will be identified from video recordings using a study-specific structured coding protocol developed and piloted by two independent coders. Critical-incident codes will be summarized descriptively; no standardized scale or composite score will be calculated. Inter-rater reliability will be established on a minimum of 20% of recordings, with a target Cohen's κ ≥0.70 before full coding. |
During the approximately 12-minute NAO-guided intervention during the single study visit (Day 1)
|
Collaboratori e investigatori
Sponsor
Investigatori
- Investigatore principale: Julie Robillard, PhD, University of British Columbia
Pubblicazioni e link utili
Pubblicazioni generali
- Bowen DJ, Kreuter M, Spring B, Cofta-Woerpel L, Linnan L, Weiner D, Bakken S, Kaplan CP, Squiers L, Fabrizio C, Fernandez M. How we design feasibility studies. Am J Prev Med. 2009 May;36(5):452-7. doi: 10.1016/j.amepre.2009.02.002.
- Hennink M, Kaiser BN. Sample sizes for saturation in qualitative research: A systematic review of empirical tests. Soc Sci Med. 2022 Jan;292:114523. doi: 10.1016/j.socscimed.2021.114523. Epub 2021 Nov 2.
- Patel DR, Neelakantan M, Pandher K, Merrick J. Cerebral palsy in children: a clinical overview. Transl Pediatr. 2020 Feb;9(Suppl 1):S125-S135. doi: 10.21037/tp.2020.01.01.
- Verschuren O, Peterson MD, Balemans AC, Hurvitz EA. Exercise and physical activity recommendations for people with cerebral palsy. Dev Med Child Neurol. 2016 Aug;58(8):798-808. doi: 10.1111/dmcn.13053. Epub 2016 Feb 7.
- Avery KN, Williamson PR, Gamble C, O'Connell Francischetto E, Metcalfe C, Davidson P, Williams H, Blazeby JM; members of the Internal Pilot Trials Workshop supported by the Hubs for Trials Methodology Research. Informing efficient randomised controlled trials: exploration of challenges in developing progression criteria for internal pilot studies. BMJ Open. 2017 Feb 17;7(2):e013537. doi: 10.1136/bmjopen-2016-013537.
- Lancaster GA, Thabane L. Guidelines for reporting non-randomised pilot and feasibility studies. Pilot Feasibility Stud. 2019 Oct 6;5:114. doi: 10.1186/s40814-019-0499-1. eCollection 2019.
- Sakzewski L, Reedman SE, Elliott C, Ziviani J, Novak I, Trost S, Majnemer A, Comans T, Shikako K, Ware RS, McNamara L, Williams S, Keramat SA, Brookes D, Boyd RN. Participate CP 2: optimising participation in physically active leisure for children with cerebral palsy - protocol for a phase III randomised controlled trial. BMJ Open. 2023 Oct 3;13(10):e075570. doi: 10.1136/bmjopen-2023-075570.
- Fragala-Pinkham M, O'Neil ME, Lennon N, Forman JL, Trost SG. Validity of the OMNI rating of perceived exertion scale for children and adolescents with cerebral palsy. Dev Med Child Neurol. 2015 Aug;57(8):748-53. doi: 10.1111/dmcn.12703. Epub 2015 Jan 27.
- Buitrago JA, Bolanos AM, Caicedo Bravo E. A motor learning therapeutic intervention for a child with cerebral palsy through a social assistive robot. Disabil Rehabil Assist Technol. 2020 Apr;15(3):357-362. doi: 10.1080/17483107.2019.1578999. Epub 2019 Feb 26.
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- H26-01002
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
Individual participant data will not be made available to external researchers. Study data will be de-identified and stored securely on UBC OneDrive, with access limited to the research team, and retained for five years after publication in accordance with the approved ethics protocol.
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .